Lundbeck expresses interest in buying Xeris, Bloomberg News reports
Danish drugmaker H Lundbeck A/S has expressed interest in acquiring Xeris Biopharma NASDAQ:XERS, Bloomberg News reported on Tuesday, citing people familiar with the matter.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.